Efficacy of Probiotics Supplementation On Chronic Kidney Disease: a Systematic Review and Meta-Analysis

被引:56
|
作者
Jia, Linpei [1 ]
Jia, Qiang [1 ]
Yang, Jingyan [2 ]
Jia, Rufu [2 ]
Zhang, Hongliang [3 ]
机构
[1] Capital Med Univ, Dept Nephrol, Xuanwu Hosp, Beijing, Peoples R China
[2] Cent Hosp Cangzhou, Cangzhou, Peoples R China
[3] Natl Nat Sci Fdn China, Dept Life Sci, Beijing, Peoples R China
来源
KIDNEY & BLOOD PRESSURE RESEARCH | 2018年 / 43卷 / 05期
关键词
Probiotics; Chronic kidney disease; Uremic toxin; Intestinal microbiota; Randomized controlled trial; P-CRESOL; CARDIOVASCULAR RISK; SYNBIOTIC TREATMENT; GUT MICROBIOTA; RENAL-FAILURE; DOUBLE-BLIND; JAK-STAT; HEALTHY; MICROFLORA; CYTOKINE;
D O I
10.1159/000494677
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Background/Aims: Dysbiosis of the intestinal microbiota may accelerate the progression of chronic kidney disease (CKD) by increasing the levels of urea toxins. In recent years, probiotics have been recognized to maintain the physiological balance of the intestinal microbiota. In this study, we aim to assess the therapeutic effects of probiotics on CKD patients with and without dialysis via meta-analysis. Methods: We conducted a meta-analysis of randomized controlled trials (RCTs) by searching the databases of Pubmed, EMBASE and Cochrane Library (No. CRD42018093080). Studies on probiotics for treatment of CKD adults lasting for at least 4 weeks were selected. The primary outcomes were the levels of urea toxins, and the second outcomes were the levels of interleukin (IL)-6, C-reactive protein (CRP) and hemoglobin (Hb). The risk of bias was assessed by Cochrane Collaboration' tool, and the quality of evidence was appraised with the Grading of Recommendation Assessment. Means and standard deviations were analyzed by random effects analysis. Stratified analysis was done and sensitivity analysis was performed when appropriate. Results: Totally, eight studies with 261 patients at CKD stage 3 to 5 with and without dialysis were included. We found a decrease of p-cresyl sulfate (PCS) of 3 studies with 125 subjects (P = 0.01, SMD-0.57, 95% CI,-0.99 to-0.14, /2 = 25%) and an increase of IL-6 in 3 studies with 134 subjects (P = 0.03, 95% CI, SMD 0.37, 0.03 to 0.72, /2 = 0%) in the probiotics groups. Analysis of serum creatinine (P = 0.47), blood urine nitrogen (P = 0.73), CRP (P = 0.55) and Hb (P = 0.49) yielded insignificant difference. Conclusion: Limited number of studies and small sample size are limitations of our study. Probiotics supplementation may reduce the levels of PCS and elevate the levels of IL-6 whereby protecting the intestinal epithelial barrier of patients with CKD. (C) 2018 The Author(s) Published by S. Karger AG, Basel
引用
收藏
页码:1623 / 1635
页数:13
相关论文
共 50 条
  • [1] Efficacy of probiotics/synbiotics supplementation in patients with chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials
    Liu, Chang
    Yang, Letian
    Wei, Wei
    Fu, Ping
    FRONTIERS IN NUTRITION, 2024, 11
  • [2] Probiotics, prebiotics and synbiotics for chronic kidney disease: protocol for a systematic review and meta-analysis
    Pei, Ming
    Wei, Lijuan
    Hu, Shouci
    Yang, Bo
    Si, Jinhua
    Yang, Hongtao
    Zhai, Jingbo
    BMJ OPEN, 2018, 8 (07):
  • [3] Prebiotic, Probiotic, and Synbiotic Supplementation in Chronic Kidney Disease: A Systematic Review and Meta-analysis
    McFarlane, Catherine
    Ramos, Christiane, I
    Johnson, David W.
    Campbell, Katrina L.
    JOURNAL OF RENAL NUTRITION, 2019, 29 (03) : 209 - 220
  • [4] Efficacy of probiotics in inflammatory bowel disease: systematic review and meta-analysis
    Derwa, Y.
    Gracie, D. J.
    Hamlin, P. J.
    Ford, A. C.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S398 - S399
  • [5] Systematic review with meta-analysis: the efficacy of probiotics in inflammatory bowel disease
    Derwa, Y.
    Gracie, D. J.
    Hamlin, P. J.
    Ford, A. C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 46 (04) : 389 - 400
  • [6] The efficacy of probiotics supplementation for the treatment of atopic dermatitis in adults: a systematic review and meta-analysis
    Li, Yajia
    Zhang, Beisi
    Guo, Jia
    Cao, Ziqin
    Shen, Minxue
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (06) : 2800 - 2809
  • [7] The Efficacy of Shen Shuaining Capsule on Chronic Kidney Disease: A Systematic Review and Meta-Analysis
    Wang, Shanshan
    Zhang, Jinfeng
    Guo, Ming
    Lian, Xiaobo
    Sun, Miaomiao
    Guo, Lizhong
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2016, 2016
  • [8] The efficacy and safety of sacubitril/valsartan in chronic kidney disease: a systematic review and meta-analysis
    Zhou, Wei
    Yang, Xinyue
    Jin, JingJing
    Cheng, Meijuan
    Li, Yajing
    Bai, Yaling
    Xu, Jinsheng
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, 56 (01) : 181 - 190
  • [9] The efficacy and safety of sacubitril/valsartan in chronic kidney disease: a systematic review and meta-analysis
    Wei Zhou
    Xinyue Yang
    JingJing Jin
    Meijuan Cheng
    Yajing Li
    Yaling Bai
    Jinsheng Xu
    International Urology and Nephrology, 2024, 56 : 181 - 190
  • [10] Probiotics supplementation in children with asthma: A systematic review and meta-analysis
    Lin, Jilei
    Zhang, Yin
    He, Chunyan
    Dai, Jihong
    JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2018, 54 (09) : 953 - 961